Sichuan Joint-Wit Medical & Pharmaceutical Industry Company Limited Company Profile - Aug 10, 2011 by WrightReports

VIEWS: 14 PAGES: 10

Sichuan Joint-Wit Medical & Pharmaceutical Industry Co., Ltd is principally engaged in the processing of Chinese traditional medical materials and patent medicines. The Company is also involved in the investment and development of health products, foods, cosmetics and medical equipment, the research, development, transfer and service of relative technology, the provision of medical and healthcare services, as well as the investment of pharmaceuticals. The Company's main products include oral solutions, granules, capsules and tablets, among others. The Company distributes its products within domestic markets. As of December 31, 2010, the Company had one major subsidiary, engaged in the production of pharmaceutical preparations.

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Sichuan Joint-Wit Medical & Pharmaceutical
   Industry Company Limited                                                               440 Wheelers Farms Road
                                                                                          Milford, CT 06461 U.S.A.



  COMPANY PROFILE
  Figures in Chinese Renmimbi

                                 Wright Quality Rating:CCNN                               Key Data

   Sichuan Joint-Wit Medical & Pharmaceutical Industry Co., Ltd is principally engaged    Ticker:
   in the processing of Chinese traditional medical materials and patent medicines. The   000809
   Company is also involved in the investment and development of health products,
   foods, cosmetics and medical equipment, the research, development, transfer and        2010 Sales:
   service of relative technology, the provision of medical and healthcare services, as
                                                                                          149,213,000
   well as the investment of pharmaceuticals. The Company's main products include
   oral solutions, granules, capsules and tablets, among others. The Company
   distributes its products within domestic markets. As of December 31, 2010, the         Major Industry:
   Company had one major subsidiary, engaged in the production of pharmaceutical          Drugs, Cosmetics & Health
   preparations.                                                                          Care
                       Stock Chart                                Officers
                                                                  Chairman                Sub Industry:
                                                                  Wei Feng                Ethical Drug Manufacturers

                                                          Deputy General Manager &        Country:
                                                            Chief Financial Officer       China
                                                                Shaoqiang Tan
                                                                                          Currency:
                                                                                          Chinese Renmimbi

                                                                                          Fiscal Year Ends:
                                                                                          December

                                                                                          Employees
                                                                                          378

                                                                                          Exchanges:
                                                                                          SZN

                                                                                          Share Type:
             Stock Price (8/5/2011): 23.79                                                A Gu
               Recent stock performance
                  1 Week       -7.5%
                                                                                          Market Capitalization:
                  4 Weeks     -10.5%
                                                                                          2,725,620,300
                  13 Weeks     -4.5%
             
								
To top